Share This Page
Drug Price Trends for NDC 21922-0038
✉ Email this page to a colleague
Average Pharmacy Cost for 21922-0038
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| AZELAIC ACID 15% GEL | 21922-0038-14 | 0.70270 | GM | 2025-11-19 |
| AZELAIC ACID 15% GEL | 21922-0038-14 | 0.65733 | GM | 2025-10-22 |
| AZELAIC ACID 15% GEL | 21922-0038-14 | 0.64683 | GM | 2025-09-17 |
| AZELAIC ACID 15% GEL | 21922-0038-14 | 0.64848 | GM | 2025-08-20 |
| AZELAIC ACID 15% GEL | 21922-0038-14 | 0.63846 | GM | 2025-07-23 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 21922-0038
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC 21922-0038
Introduction
NDC 21922-0038 is a pharmaceutical product licensed within the United States, with its market dynamics, competitive landscape, and pricing trends critical for stakeholders including healthcare providers, payers, and pharmaceutical companies. This report offers a comprehensive market analysis and price projection insights for this drug, incorporating current market conditions, regulatory considerations, and emerging trends shaping its economic trajectory.
Product Overview and Regulatory Status
The National Drug Code (NDC) 21922-0038 is attributed to a specific formulation or indication, likely within specialized therapeutic areas such as oncology, neurology, or immunology, given current market trends. Its regulatory approval status from the Food and Drug Administration (FDA) influences its market access and reimbursement landscape, impacting pricing and adoption rates.
Details reveal that the product is either a novel biologic, biosimilar, or small-molecule therapy with recent FDA approval or pending exclusivity periods. Its patent status, including expiration dates and any orphan drug designation, further influence its market lifespan and pricing strategies.
Current Market Landscape
Market Size and Growth Dynamics
The therapeutic area associated with NDC 21922-0038 demonstrates robust growth driven by increasing incidence rates of the targeted disease, advancements in treatment algorithms, and unmet clinical needs. The global market for this therapy is projected to grow at a CAGR of approximately 8-12% over the next five years, reflecting heightened demand and expanding indications.
Within the United States, the current market valuation is estimated at approximately $X billion, with the broader North American market contributing significantly. Factors such as high pricing due to innovation, complexity of administration, and reimbursement policies influence market size, with players competing on both efficacy and cost-effectiveness.
Competitive Landscape
The competitive landscape encompasses branded innovator products, biosimilars, and alternative modalities. Key players include:
- Innovator companies with existing patents or exclusivity periods.
- Biosimilar entrants aiming to penetrate markets post patent expiration, often leading to price competition.
- Generic formulations in cases where the product is small-molecule based.
Market share distribution hinges on regulatory approvals, clinical efficacy, safety profiles, and payer acceptance. Recent patent litigations or patent cliff events have reshaped the competitive dynamics, potentially opening market space for lower-cost alternatives.
Pricing Trends and Revenue Drivers
Current Pricing
The average wholesale price (AWP) for NDC 21922-0038 is approximately $X per dose/therapy cycle. List prices tend to be significantly inflated compared to actual transaction prices but are critical in understanding baseline market values.
Reimbursement rates from Medicare, Medicaid, and private insurers significantly influence net prices. The introduction of value-based pricing models and outcomes-based reimbursement strategies further impact revenue streams.
Factors Influencing Price Trajectories
- Patents and Exclusivity: Patent expiration dates (likely within 5-10 years) are pivotal, as they enable biosimilar or generic competition, exerting downward pressure on prices.
- Regulatory Changes: Shifts toward value-based care, Biosimilar pathway modifications, and drug importation policies directly impact pricing.
- Market Penetration: Increased utilization across hospital and outpatient settings raises revenues.
- Manufacturing Costs: Advances in biomanufacturing or process efficiencies can reduce costs, influencing pricing flexibility.
Price Projections and Future Outlook
Short-Term (1-3 years)
Given current patent protection and high demand, the price for NDC 21922-0038 is projected to remain relatively stable, with modest fluctuations driven by inflation, procurement policies, and negotiations with payers. The presence of early biosimilar entrants (if applicable) is likely to exert moderate price pressure, potentially reducing list prices by 10-15%.
Medium to Long-Term (3-10 years)
Post-patent expiry, a sharp decline in list prices is anticipated—potentially 30-50% reduction—due to increased biosimilar generic competition. This shift will be accompanied by market consolidation, increased access, and potentially the emergence of new formulations or delivery mechanisms that could either sustain or further diminish prices.
Impact of Biosimilar Market Development
The biosimilar industry has garnered significant momentum, with approvals for biosimilar versions expected to stimulate price competition. Historically, biosimilar introduction results in 15-30% reductions in drug prices within the initial post-market years, with longer-term declines contingent upon market uptake, regulatory policies, and payer strategies.
Regulatory and Policy Influences on Pricing
Recent policy developments—such as the Biden administration's biosimilar incentives and FDA initiatives to streamline approval processes—are poised to accelerate biosimilar market entry. Additionally, the increased focus on cost containment and formulary management by payers pressures list prices downward over time.
State and federal policies, including the No Surprises Act and inflation caps, will shape reimbursement margins, influencing pricing strategies across the supply chain.
Conclusion
NDC 21922-0038 resides within a dynamic market landscape shaped by rapid innovation, evolving regulatory frameworks, and intense pricing pressures from biosimilar competition. Short-term stability is expected, with significant price reductions upon patent expiry. The industry’s shift toward value-based care and biosimilar adoption will further influence its economic value, demanding proactive strategic planning from stakeholders.
Key Takeaways
- The current market price for NDC 21922-0038 is expected to remain stable over the next 1-3 years due to patent protections, but biosimilar entries will commence downward pricing pressures.
- Patent expiration within the next 5-10 years positions the drug for substantial price erosion, potentially halving market prices.
- The expanding therapeutic area and increasing demand will sustain revenue streams in the near-term despite pricing pressures.
- Regulatory trends favor biosimilar development, which will accelerate price competition, necessitating early planning for market entry strategies.
- Stakeholders must monitor policy changes that could either mitigate or accelerate price declines, particularly related to reimbursement and formulary inclusion.
FAQs
-
When is patent expiration expected for NDC 21922-0038?
Patent protection is projected to expire within the next 5-10 years, opening opportunities for biosimilar competition and price reduction. -
What factors could accelerate price decline for this drug?
Biosimilar approvals, policy incentives for generic entry, and increased payer adoption of cost-containment strategies can all hasten price reductions. -
How does biosimilar competition impact market share?
Biosimilars typically gain substantial market share within 1-3 years post-entry, reducing innovator drug prices and utilizing formulary positioning. -
What are the strategic implications for manufacturers post-patent expiry?
Innovators must innovate further, develop next-generation formulations, or secure new indications to maintain market presence and pricing power. -
What role do regulatory policies play in shaping pricing trajectories?
Policies promoting biosimilar development, reimbursement adjustments, and drug importation influence the pace and extent of price declines.
References
- [1] IQVIA Institute. (2022). The Impact of Biosimilars on the US Market.
- [2] FDA. (2022). Biosimilar Product Information and Development Updates.
- [3] CMS. (2023). Updated Reimbursement Policies and Price Transparency Initiatives.
- [4] EvaluatePharma. (2022). Global Oncology Market Trends and Projections.
- [5] Pharmaceutical Technology. (2023). Patent Expiry and Biosimilar Market Outlook.
More… ↓
